|
Volumn 328, Issue 5980, 2010, Pages 825-826
|
Risks of immune system treatments
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOIMMUNE DISEASE;
BONE MARROW DEPRESSION;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CELL REGENERATION;
FUNDING;
GOVERNMENT;
HEALTH CARE COST;
HEALTH SERVICE;
HEMATOPOIETIC STEM CELL;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
IMMUNOTHERAPY;
INFERTILITY;
INFLAMMATION;
LETTER;
LYMPHOCYTE;
METASTASIS;
NONHUMAN;
PATIENT SAFETY;
PRIORITY JOURNAL;
REMISSION;
RESEARCH;
RISK;
STEM CELL TRANSPLANTATION;
UNITED STATES;
|
EID: 77952341386
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.328.5980.825-e Document Type: Letter |
Times cited : (17)
|
References (10)
|